Viewing Study NCT04220632


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-02-20 @ 1:31 PM
Study NCT ID: NCT04220632
Status: TERMINATED
Last Update Posted: 2020-10-29
First Post: 2020-01-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CIBI377A201
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators